Alzheimer’s: A Turning Point?

Two new drugs that can be used to slow the progression of Alzheimer's disease, donanemab and lecanemab, represent a turning point in Alzheimer's research, believes Dr Cath Mummery (UCL Queen Square Institute of Neurology), but she adds they are "just the beginning".

Watch: BBC One 'Panorama' (from 5 mins 30 secs), Listen: BBC Radio 4 'News Briefing' (from 3 mins 12 secs)